urine infection

SIGN guideline

SIGN guideline on bacterial UTIs in women

2020-11-16T13:42:00+00:00By

This guidance provides advice on the managment of suspected bacterial lower urinary tract infection in adult women

checklist

Independent professional body guideline

FSRH UKMEC contraception guideline

2020-06-23T00:00:00+01:00By

A summary of the FSRH UKMEC guidance on the safety of contraceptive methods, which is set out in clear and concise tables.

AdobeStock_247826679

NICE guideline

NICE CKS candida—female genital

2020-04-02T14:04:00+01:00By

This summary has been developed for use by community pharmacists under our Guidelines for Pharmacy title and therefore only covers the information relevant to this setting.

Doctor explaining diagnosis to woman pointing at laptop

NICE guideline

NICE menopause guideline

2019-12-19T00:00:00+00:00By

This summary covers diagnosis, treatment options, and includes a useful care algorithm for the management of menopause.

Doctor In Consultation With Female Patient In Office

NICE guideline

NICE recommendations for women with urinary incontinence

2019-04-26T08:33:00+01:00By

Summary of NICE guidance covers history taking, assessing urinary incontinence, investigations, non-surgical management, and indicators for referral.

Female doctor with lady patient_AS206x137

Working party guideline/algorithm

Uncomplicated recurrent UTI guideline

2019-03-19T09:07:00+00:00By Working party—Rees Brocksom Harding Jacobson Rollinson

This guideline was developed by a multidisciplinary expert panel: Rees J et al with the support of a grant from Aspire Pharma Ltd.

contraceptive pills_AS_247x165

Independent professional body guideline

FSRH CHC guideline

2019-02-18T14:51:00+00:00By

This concise updated summary of the FRSH combined hormonal contraception guideline covers use, effectiveness, non-contraceptive benefits, and risks.

condoms on yellow background_AS

Independent professional body guideline

FSRH contraception after pregnancy guideline

2018-02-26T10:00:00+00:00By

This summary of the FSRH guidance on contraception after pregnancy focuses specifically on contraception after pregnancy and childbirth

hands holding pills

Independent professional body guideline

FSRH emergency contraception (EC) guideline

2017-10-23T14:34:00+01:00By

This summary of FSRH EC guidance compares the effectiveness of EC methods and decision-making based on patients’ needs, including helpful algorithms.

hand with medicine in pills and glass of water_AS

Independent professional body guideline

PCWHF menopause HRT prescribing guideline

2017-09-29T00:00:00+01:00By

This concise summary developed by the Primary Care Women’s Health Forum is designed to provide support when initiating therapy, or to support in choosing alternative preparations, for the treatment of symptoms of the menopause.

Resource hub

  • Making the case for preconception care

  • Having a smear test—what is it about?

  • Human papillomavirus (HPV) vaccination and cervical cancer—addressing the myths

  • Your guide to staying active in pregnancy

  • Pain and symptom diary

Educational resources

X-ray (female pelvis) 397x302

Osteoporotic fracture guideline

By Working party—Cooper Javaid Elliott Stephens Tanna

This guideline was developed by a multidisciplinary expert panel: Cooper C et al with the support of an educational grant from UCB Pharma Ltd.

Preconception advice

Women of child-bearing age with inflammatory rheumatic diseases guideline

By Working party—Giles Allen Nelson-Piercy Tower Warburton Gordon

This guideline was developed by a multidisciplinary expert panel: Giles I et al with the support of an educational grant from UCB Pharma Ltd.

Mylan HRT evidence update cover

The importance of the progestogenic component of hormone replacement therapy in women with a uterus

Funded by Mylan

Dr John Stevenson and Dr Sophia Tsiligiannis discuss progestogen prescribing in hormone replacement therapy.

Female doctor with lady patient_AS206x137

Uncomplicated recurrent UTI guideline

By Working party—Rees Brocksom Harding Jacobson Rollinson

This guideline was developed by a multidisciplinary expert panel: Rees J et al with the support of a grant from Aspire Pharma Ltd.